5-179345258-GGCAGCAGCAGCA-GGCAGCAGCAGCAGCAGCA
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The ENST00000251582.12(ADAMTS2):c.70_71insTGCTGC(p.Leu22_Leu23dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,136,418 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 28)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
ADAMTS2
ENST00000251582.12 inframe_insertion
ENST00000251582.12 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
ADAMTS2 (HGNC:218): (ADAM metallopeptidase with thrombospondin type 1 motif 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 5-179345258-G-GGCAGCA is Benign according to our data. Variant chr5-179345258-G-GGCAGCA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 506736.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=3}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS2 | NM_014244.5 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion | 1/22 | ENST00000251582.12 | NP_055059.2 | |
ADAMTS2 | NM_021599.4 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion | 1/11 | NP_067610.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS2 | ENST00000251582.12 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion | 1/22 | 1 | NM_014244.5 | ENSP00000251582 | P2 | |
ADAMTS2 | ENST00000274609.5 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion | 1/11 | 1 | ENSP00000274609 | |||
ADAMTS2 | ENST00000518335.3 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion | 1/21 | 3 | ENSP00000489888 | A2 | ||
ADAMTS2 | ENST00000698889.1 | c.70_71insTGCTGC | p.Leu22_Leu23dup | inframe_insertion, NMD_transcript_variant | 1/21 | ENSP00000514008 |
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 60AN: 146978Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
60
AN:
146978
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000896 AC: 1AN: 1116Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 680
GnomAD3 exomes
AF:
AC:
1
AN:
1116
Hom.:
AF XY:
AC XY:
0
AN XY:
680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000229 AC: 227AN: 989348Hom.: 0 Cov.: 29 AF XY: 0.000261 AC XY: 123AN XY: 472142
GnomAD4 exome
AF:
AC:
227
AN:
989348
Hom.:
Cov.:
29
AF XY:
AC XY:
123
AN XY:
472142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000415 AC: 61AN: 147070Hom.: 0 Cov.: 28 AF XY: 0.000251 AC XY: 18AN XY: 71648
GnomAD4 genome
AF:
AC:
61
AN:
147070
Hom.:
Cov.:
28
AF XY:
AC XY:
18
AN XY:
71648
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2022 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | ADAMTS2: BS2 - |
Ehlers-Danlos syndrome, dermatosparaxis type Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | This variant, c.65_70dup, results in the insertion of 2 amino acid(s) of the ADAMTS2 protein (p.Leu22_Leu23dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ADAMTS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 506736). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 11, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at